Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments

Overview of attention for article published in Frontiers in Neurology, February 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

blogs: 1 blog

twitter: 4 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 22 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 16,534 followers.

Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments https://t.co/QBXhxf61Yb

16 Mar 2022

Reply Repost Favourite

New article: Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments https://t.co/4qd61TBHaE #MS #multiplesclerosis #neurology https://t.co/ASlNuX2A11

14 Mar 2022

Reply Repost Favourite

5,347/ Massachusetts, USA (adult current smoking rate was 11.1% in 2020) ES=ever smoking Of 58 with CNS demyelinating disorders & prior suspected or confirmed COVID-19 infection tested for antibodies, ES=39.7% 24 positive: ES=45.8% https://t.co/7g

11 Mar 2022

Reply Repost Favourite

New Research: Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments: With unclear characteristics of post-infection and post-vaccination immunity, the multiple sclerosis community lacks… https://t.co/5W

23 Feb 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.